Publication:
Bmi1-Progenitor Cell Ablation Impairs the Angiogenic Response to Myocardial Infarction.

dc.contributor.authorHerrero, Diego
dc.contributor.authorCañón, Susana
dc.contributor.authorPelacho, Beatriz
dc.contributor.authorSalvador-Bernáldez, María
dc.contributor.authorAguilar, Susana
dc.contributor.authorPogontke, Cristina
dc.contributor.authorCarmona, Rosa María
dc.contributor.authorSalvador, Jesús María
dc.contributor.authorPerez-Pomares, Jose María
dc.contributor.authorKlein, Ophir David
dc.contributor.authorPrósper, Felipe
dc.contributor.authorJimenez-Borreguero, Luis Jesús
dc.contributor.authorBernad, Antonio
dc.date.accessioned2023-01-25T10:20:31Z
dc.date.available2023-01-25T10:20:31Z
dc.date.issued2018
dc.description.abstractObjective- Cardiac progenitor cells reside in the heart in adulthood, although their physiological relevance remains unknown. Here, we demonstrate that after myocardial infarction, adult Bmi1+ (B lymphoma Mo-MLV insertion region 1 homolog [PCGF4]) cardiac cells are a key progenitor-like population in cardiac neovascularization during ventricular remodeling. Approach and Results- These cells, which have a strong in vivo differentiation bias, are a mixture of endothelial- and mesenchymal-related cells with in vitro spontaneous endothelial cell differentiation capacity. Genetic lineage tracing analysis showed that heart-resident Bmi1+ progenitor cells proliferate after acute myocardial infarction and differentiate to generate de novo cardiac vasculature. In a mouse model of induced myocardial infarction, genetic ablation of these cells substantially deteriorated both heart angiogenesis and the ejection fraction, resulting in an ischemic-dilated cardiac phenotype. Conclusions- These findings imply that endothelial-related Bmi1+ progenitor cells are necessary for injury-induced neovascularization in adult mouse heart and highlight these cells as a suitable therapeutic target for preventing dysfunctional left ventricular remodeling after injury.
dc.identifier.doi10.1161/ATVBAHA.118.310778
dc.identifier.essn1524-4636
dc.identifier.pmcPMC6202133
dc.identifier.pmid29930004
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202133/pdf
dc.identifier.unpaywallURLhttps://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.118.310778
dc.identifier.urihttp://hdl.handle.net/10668/12630
dc.issue.number9
dc.journal.titleArteriosclerosis, thrombosis, and vascular biology
dc.journal.titleabbreviationArterioscler Thromb Vasc Biol
dc.language.isoen
dc.organizationCentro Andaluz de Nanomedicina y Biotecnología-BIONAND
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.page.number2160-2173
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, N.I.H., Extramural
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectcell differentiation
dc.subjectlymphoma
dc.subjectmyocardial infarction
dc.subjectphenotype
dc.subjectventricular remodeling
dc.subject.meshAnimals
dc.subject.meshCells, Cultured
dc.subject.meshDisease Models, Animal
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMice
dc.subject.meshMice, Transgenic
dc.subject.meshMyocardial Infarction
dc.subject.meshMyocytes, Cardiac
dc.subject.meshNeovascularization, Pathologic
dc.subject.meshPolycomb Repressive Complex 1
dc.subject.meshProto-Oncogene Proteins c-kit
dc.subject.meshStem Cells
dc.subject.meshTranscription Factors
dc.subject.meshVentricular Remodeling
dc.titleBmi1-Progenitor Cell Ablation Impairs the Angiogenic Response to Myocardial Infarction.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number38
dspace.entity.typePublication

Files